1. Apoptosis
    Autophagy
  2. Apoptosis
    Autophagy
  3. Luteolin

Luteolin (Synonyms: Luteoline; Luteolol; Digitoflavone)

Cat. No.: HY-N0162 Purity: 98.14%
Handling Instructions

Luteolin (Luteolol) is a flavanoid with anti-inflammatory, anti-cancer properties, including the induction of apoptosis and cell cycle arrest, and the inhibition of metastasis and angiogenesis, in several cancer cell lines, including human non-small lung cancer cells.

For research use only. We do not sell to patients.

Luteolin Chemical Structure

Luteolin Chemical Structure

CAS No. : 491-70-3

Size Price Stock Quantity
Free Sample (0.5-1 mg)   Apply now  
10 mM * 1 mL in DMSO USD 55 In-stock
Estimated Time of Arrival: December 31
10 mg USD 50 In-stock
Estimated Time of Arrival: December 31
50 mg USD 60 In-stock
Estimated Time of Arrival: December 31
100 mg USD 70 In-stock
Estimated Time of Arrival: December 31
500 mg USD 210 In-stock
Estimated Time of Arrival: December 31
1 g   Get quote  
5 g   Get quote  

* Please select Quantity before adding items.

Customer Review

Based on 2 publication(s) in Google Scholar

Top Publications Citing Use of Products

Publications Citing Use of MCE Luteolin

    Luteolin purchased from MCE. Usage Cited in: Front Pharmacol. 2018 Jun 13;9:620.

    Effects of Luteolin on the level of CTSD and p-CDK2 in HK-2 cells. The western blotting results of CTSD and p-CDK2 in the NaOx-stimulated HK-2 cells treated by Luteolin.
    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Luteolin (Luteolol) is a flavanoid with anti-inflammatory, anti-cancer properties, including the induction of apoptosis and cell cycle arrest, and the inhibition of metastasis and angiogenesis, in several cancer cell lines, including human non-small lung cancer cells[1][2].

    In Vitro

    Luteolin (0-160 µM; 24 hours; NCI-H460 cells) treatment inhibits the viability of NCI-H460 cells in a concentration-dependent manner[1].
    Luteolin (20-80 µM; 24 hours; NCI-H460 cells) treatment causes an accumulation of cells in the S phase[1].
    Luteolin (320-580 µM; 48 hours; NCI-H460 cells) treatment induces apoptosis[1].
    Luteolin (20-80 µM; 24 hours; NCI-H460 cells) treatment increases the protein expression levels of apoptotic regulatory proteins, including the Bax/Bcl-2 ratio, in a concentration-dependent manner, however, only 80 µM Luteolin inhibits the expression of Bad. Luteolin also decreases the expression of Sirt1 in the NCI-H460 cell line in a concentration-dependent manner[1].

    Cell Viability Assay[1]

    Cell Line: NCI-H460 cells
    Concentration: 0 µM, 20 µM, 40 µM, 80 µM and 160 µM
    Incubation Time: 24 hours
    Result: Inhibited the viability of NCI-H460 cells in a concentration-dependent manner.

    Cell Cycle Analysis[1]

    Cell Line: NCI-H460 cells
    Concentration: 20 µM, 40 µM, 80 µM
    Incubation Time: 24 hours
    Result: Induced cell cycle arrest in the S phase.

    Apoptosis Analysis[1]

    Cell Line: NCI-H460 cells
    Concentration: 320 µM, 440 µM, 580 µM
    Incubation Time: 48 hours
    Result: Apoptotic fraction was markedly increased.

    Western Blot Analysis[1]

    Cell Line: NCI-H460 cells
    Concentration: 20 µM, 40 µM, 80 µM
    Incubation Time: 24 hours
    Result: Increased the protein expression levels of apoptotic regulatory proteins and decreased the expression of Sirt1 in the NCI-H460 cell line in a concentration-dependent manner.
    In Vivo

    Luteolin (10-100 mg/kg; oral gavage; daily; for 12 weeks; adult male Wistar rats) has an antioxidant effect and can also protect against non-alcoholic steatohepatitis through targeting the pro-inflammatory IL-1 and Il-18 pathways in rats with a high carbohydrate/high fat diet[2].

    Animal Model: Adult male Wistar rats (200-220 g)[2]
    Dosage: 10 mg/kg, 25 mg/kg, 50 mg/kg or 100 mg/kg
    Administration: Oral gavage; daily; for 12 weeks
    Result: Significantly reduced ALT and AST activity and reduced levels of bilirubin, hyaluronic acid and malondialdehyde. Shows an antioxidant activity such as a significant increase in reduced glutathione. IFN-γ, TNF-α, IL-1α and IL-18 levels decreased significantly.
    Clinical Trial
    Molecular Weight

    286.24

    Formula

    C₁₅H₁₀O₆

    CAS No.

    491-70-3

    SMILES

    O=C1C=C(C2=CC=C(O)C(O)=C2)OC3=CC(O)=CC(O)=C13

    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage
    Powder -20°C 3 years
      4°C 2 years
    In solvent -80°C 6 months
      -20°C 1 month
    Solvent & Solubility
    In Vitro: 

    DMSO : ≥ 100 mg/mL (349.36 mM)

    *"≥" means soluble, but saturation unknown.

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 3.4936 mL 17.4679 mL 34.9357 mL
    5 mM 0.6987 mL 3.4936 mL 6.9871 mL
    10 mM 0.3494 mL 1.7468 mL 3.4936 mL
    *Please refer to the solubility information to select the appropriate solvent.
    In Vivo:
    • 1.

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% saline

      Solubility: ≥ 2.5 mg/mL (8.73 mM); Clear solution

    • 2.

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in saline)

      Solubility: ≥ 2.5 mg/mL (8.73 mM); Clear solution

    *All of the co-solvents are provided by MCE.
    References
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass   Concentration   Volume   Molecular Weight *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
    × = ×
    C1   V1   C2   V2

    KeyWords:

    Luteolin | Luteoline | Luteolol | Digitoflavone | Apoptosis | Autophagy | Inhibitor | inhibitor | inhibit

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product name

     

    Salutation

    Applicant name *

     

    Email address *

    Phone number *

     

    Organization name *

    Country or Region *

     

    Requested quantity *

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product name:
    Luteolin
    Cat. No.:
    HY-N0162
    Quantity:
    MCE Japan Authorized Agent: